Metabolomics of urinary organic acids in respiratory chain deficiencies in children

Metabolomics

Volumn 8, Issue 2, 2012, Pages 264-283

  Reinecke, Carolus J ^a   Koekemoer, Gerhard ^a   van der Westhuizen, Francois H ^a   Louw, Roan ^a   Lindeque, Jeremie Z ^a   Mienie, Lodewyk J ^a   Smuts, Izelle ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Data reduction; Global metabolite profile; Metabolomics; Respiratory chain deficiencies; Urinary organic acids

Indexed keywords

CARBOXYLIC ACID;

ACIDURIA; ADOLESCENT; AMINO ACID METABOLISM; ARTICLE; CARBOHYDRATE METABOLISM; CHILD; CLINICAL ARTICLE; COMPLEX I DEFICIENCY; COMPLEX II DEFICIENCY; COMPLEX III DEFICIENCY; CONTROLLED STUDY; CYTOCHROME C OXIDASE DEFICIENCY; FATTY ACID METABOLISM; HUMAN; INBORN ERROR OF METABOLISM; MASS FRAGMENTOGRAPHY; METABOLOMICS; PRESCHOOL CHILD; SCHOOL CHILD; URINALYSIS;

EID: 84857794136     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0309-0     Document Type: Article

References (73)

1. Anderson, S., Bankier, A. T., & Barrell, B. G. (1981). Sequence and organization of the human mitochondrial genome. Nature, 290, 457-465.
2. Baker, M., & Rayens, W. (2003). Partial least squares for discrimination. Journal of Chemometrics, 17, 166-173.
3. Banaszak, L. J., & Bradshaw, R. A. (1975). Malate dehydrogenases. In P. D. Boyer (Ed.), The enzymes, 11 oxidation-reduction part A (pp. 369-396). New York, San Francisco, London: Academic Press.
4. Barshop, B. A. (2004). Metabolomic approaches to mitochondrial disease: Correlation of urine organic acids. Mitochondrion, 4, 521-527.
5. Barshop, B. A., Nyhan, W. L., Naviaux, R. K., et al. (2000). Kearns-Sayre syndrome presenting as 2-oxoadipic aciduria. Molecular Genetics and Metabolism, 69, 64-68.
6. Beeckman, S., & Kanarek, L. (1981). Demonstration of physical interactions between consecutive enzymes of the citric acid cycle and of the aspartate-malate shuttle. European Journal of Biochemistry, 117, 527-535.
7. Bennett, M. J., Sherwood, W. G., Gibson, K. M., & Burlina, A. B. (1993). Secondary inhibition of multiple NAD-requiring dehydrogenases in respiratory chain complex I deficiency: Possible metabolic markers for the primary defect. Journal of Inherited Metabolic Disease, 16, 560-562.
8. Bennett, M. J., Weinberger, M. J., Sherwood, W. G., & Burlina, A. B. (1994). Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease, 17, 283-286.
9. Bernier, F. P., Boneh, A., Dennett, X., et al. (2002). Diagnostic criteria for respiratory chain disorders in adults and children. Neurology, 59, 1406-1411.
10. Bijlsma, S., Bobeldijk, I., Verheij, E. R., et al. (2006). Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation. Analytical Chemistry, 78, 567-574.
11. Boekema, E. J., & Braun, H.-P. (2007). Supramolecular structure of the mitochondrial oxidative phosphorylated system. Journal of Biological Chemistry, 282, 1-4.
12. Buckel, W., & Miller, S. L. (1987). Equilibrium constants of several reactions involved in the fermentation of glutamate. European Journal of Biochemistry, 164, 565-569.
13. Carraro, S., Giordano, G., Reniero, F., Perilongo, G., & Baraldi, E. (2009). Metabolomics: A new frontier for research in pediatrics. Journal of Pediatrics, 154, 638-644.
14. © and backflush improves the speed and accuracy of data processing for urinary organic acid analysis. Clinica Chimica Acta, 405, 53-59.
15. Christensen, E., Brandt, N. J., Schmalbruch, H., et al. (1993). Muscle cytochrome c oxidase deficiency accompanied by a urinary organic acid pattern mimicking multiple acyl-CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease, 16, 553-556.
16. DiMauro, S., & Andreu, A. L. (2000). Mutations in mtDNA: Are we scraping the bottom of the barrel? Brain Pathology, 10, 431-441.
17. Dudkina, N. V., Sunderhaus, S., Boekema, E. J., & Braun, H.-P. (2008). The higher level of organization of the oxidative phosphorylation system: Mitochondrial supercomplexes. Journal of Bioenergetics and Biomembranes, 40, 419-424.
18. Dunn, W. B., & Ellis, D. I. (2005). Metabolomics: Current analytical platforms and methodologies. Trends in Analytical Chemistry, 24, 285-294.
19. Duran, M. (2005). Disorders of mitochondrial fatty acid oxidation. In N. Blau, M. Duran, & M. E. Blaskovics (Eds.), Physician's guide to the laboratory diagnosis of metabolic diseases (Revised 2nd ed., pp. 309-334). Heidelberg: Springer.
20. Duran, M., Beemer, F. A., Tibosch, A. S., et al. (1982). Inherited 3-methylglutaconic aciduria in two brothers-another defect of leucine metabolism. Journal of Pediatrics, 101, 551-554.
21. Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H., & Wadman, S. K. (1980). l-2-hydroxyglutaric aciduria: An inborn error of metabolism? Journal of Inherited Disease, 3, 109-112.
22. Ellis, S. M., & Steyn, H. S. (2003). Practical significance (effect sizes) versus or in combination with statistical significance (p-values). Management Dynamics, 12, 51-53.
23. Enns, G. M., Bennett, M. J., Hoppel, C. L., et al. (2000). Mitochondrial respiratory chain complex I deficiency with clinical and biochemical features of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Journal of Pediatrics, 136, 251-254.
24. Erasmus, C., Mienie, L. J., Reinecke, C. J., & Wadman, S. K. (1985). Organic aciduria in late-onset biotin-responsive multiple carboxylase deficiency. Journal of Inherited Metabolic Disease, 8, 105-106.
25. Esteitie, N., Hinttala, R., Wibom, R., et al. (2005). Secondary metabolic effects in complex I deficiency. Annals of Neurology, 58, 544-552.
26. Foulon, V., Sniekers, M., Huysmans, E., et al. (2005). Breakdown of 2-hydroxylated straight chain fatty acids via peroxisomal 2-hydroxyphytanol-CoA lyase. Journal of Biological Chemistry, 280, 9802-9812.
27. Frankenhaeuser, M., Lundberg, U., Rauste von Wright, M., von Wright, J., & Sedvall, G. (1985). Urinary monoamine metabolites as indices of mental stress in healthy male and females. Pharmacology, Biochemistry and Behaviour, 24, 1521-1525.
28. Goodacre, R., Broadhurst, D., Smilde, A. K., et al. (2007). Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics, 3, 231-241.
29. Gordon, N. (2006). Glutaric aciduria types I and II. Brain and Development, 28, 136-140.
30. Haas, R. H., Parikh, S., Falk, M. J., et al. (2008). The in-depth evaluation of suspected mitochondrial disease. Molecular Genetics and Metabolism, 94, 16-37.
31. Heinrich, R., & Rapoport, T. A. (1974). A linear steady-state treatment of enzymatic chains. European Journal of Biochemistry, 42, 89-95.
32. HMDB. (2010). Human metabolome database, Version 2. 5. Retrieved Oct 23, 2010 from http://www. hmdb. ca.
33. Hoffman, G. F., & Feyh, P. (2005). Organic acid analysis. In N. Blau, M. Duran, & M. E. Blaskovics (Eds.), Physician's guide to the laboratory diagnosis of metabolic diseases (Revised 2 ed., pp. 27-44). Heidelberg: Springer.
34. Hofhaus, G., Johns, D. R., Hurko, O., Attardi, G., & Chomyn, A. (1996). Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. Journal of Biological chemistry, 271, 13155-13161.
35. Janssen, A. J. M., Trijbels, F. J. M., Sengers, R. C. A., et al. (2007). Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clinical Chemistry, 53, 729-734.
36. Johnson, R. A., & Wichern, D. W. (1998). Applied multivariate statistical analysis (4th ed.). Englewood Cliffs: Prentice-Hall, Inc.
37. Kelley, R. I., & Kratz, L. (1995). 3-methylglutaconic acidaemia in Smith-Lemli-Opitz syndrome. Pediatric Research, 37, 671-674.
38. Korzeniewski, B. (2001). Theoretical studies on the regulation of oxidative phosphorylation in intact tissues. Biochimica et Biophysica Acta, 1504, 31-45.
39. Kumps, A., Duez, P., & Mardens, Y. (2002). Metabolic, nutritional, latrogenic, and artifactual sources of urinary organic acids: A comprehensive table. Clinical Chemistry, 48, 708-717.
40. Kurlemann, G., Paetzke, I., Möller, H., et al. (1995). Therapy of complex I deficiency: Peripheral neuropathy during dichloroacetate theraby. European Journal of Pediatrics, 154, 928-932.
41. Kuwertz-Bröking, E., Koch, H. G., Marquardt, T., et al. (2000). Renal Fanconi syndrome: First sign of partial respiratory chain complex IV deficiency. Pediatric Nephrology, 14, 495-498.
42. Lalani, S. R., Vladutiu, G. D., Plunkett, K., et al. (2005). Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Archives of Neurology, 62, 317-320.
43. Mamas, M., Dunn, W. B., Neyses, L., & Goodacre, R. (2011). The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Archives of Toxicology, 85, 5-17.
44. Mancuso, M., Orsucci, D., Coppedè, F., et al. (2009). Diagnostic approach to mitochondrial disorders: The need for a reliable biomarker. Current Molecular Medicine, 9, 1095-1107.
45. Mazat, J.-P., Rossignol, R., Malgat, M., et al. (2001). What do mitochondrial diseases teach us about normal mitochondrial functions... that we already knew: Threshold expression of mitochondrial defects. Biochimica et Biophysica Acta, 1504, 20-30.
46. Mochel, F., Slama, A., Touati, G., et al. (2005). Respiratory chain defects may present only with hypoglycemia. Journal of Clinical Endocrinology and Metabolism, 90, 3780-3785.
47. Morava, E., van den Heuvel, L., Hol, F., et al. (2006). Mitochondrial disease criteria: Diagnostic application in children. Neurology, 26, 1823-1826.
48. Morrow, D. A., & de Lemos, J. A. (2007). Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation, 115, 949-952.
49. Munnich, A., Rustin, P., Rötig, A., et al. (1992). Clinical aspects of mitochondrial disorders. Journal of Inherited Metabolic Disorders, 15, 448-455.
50. Pfeiffer, T., Schuster, S., & Bonhoeffer, S. (2001). Cooperation and competition in the evolution of ATP-producing pathways. Science, 292, 504-507.
51. Rabier, D., Diry, C., Rotig, A., et al. (1998). Persistent hypocitrullinaemia as a marker for mtDNA NARP T 8993 G mutation? Journal of Inherited Metabolic Disorder, 21, 216-219.
52. Rahman, S., Blok, R. B., Dahl, H. H., et al. (1996). Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Annals of Neurology, 39, 343-351.
53. Rauste-von Wright, M., & Frankenhaeuser, M. (1989). Females' emotionality as reflected in the excretion of the dopamine metabolite HVA during mental stress. Psychological Reports, 64, 856-858.
54. Reder, C. (1988). Metabolic control: A structural approach. Journal of Theoretical Biology, 135, 175-201.
55. Reinecke, F., Smeitink, J. A. M., & van der Westhuizen, F. H. (2009). OXPHOS gene expression and control in mitochondrial disorders. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1792, 1113-1121.
56. Rossignol, R., Faustin, B., Rocher, C., et al. (2003). Mitochondrial threshold effects. Biochemical Journal, 370, 751-762.
57. Rzem, R., Veiga-da-Cunha, M., Noël, G., et al. (2004). A gene encoding a putative FAD-dependent l-2-hydroxygluterate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proceedings of the National Academy of Sciences USA, 101, 16849-16854.
58. Shah, N. S., Mitchell, W. G., & Boles, R. G. (2002). Mitochondrial disorders: A potentially under-recognized etiology of infantile spasms. Journal of Child Neurology, 17, 369-372.
59. Shepherd, D., & Garland, P. B. (1969). The kinetic properties of citrate synthase from rat liver mitochondria. Biochemistry Journal, 114, 597-610.
60. Smeitink, J. (2003). Mitochondrial disorders: Clinical presentation and diagnostic dilemmas. Journal of Inherited Metabolic Disease, 26, 199-207.
61. Smeitink, J., Zeviani, M., Turnbull, D. M., & Jacobs, H. (2006). Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphoryation disorders. Cellular Metabolism, 3, 9-13.
62. Smuts, I., Louw, R., du Toit, H., Klopper, B., Mienie, L. J., & van der Westhuizen, F. H. (2010). An overview of a cohort of South African patients with mitochondrial disorders. Journal of Inherited Metabolic Disease. doi: 10. 1007/s10545-009-9032-8.
63. Sperl, W., Jesina, P., Zeman, J., et al. (2006). Deficiency of mitochondrial ATP synthase of nuclear genetic origin. Neuromuscular Disorders, 16, 821-829.
64. Suomalainen, A. (2010). Biomarkers for mitochondrial respiratory chain disorders. Journal of Inherited Metabolic Disease. doi: 10. 1007/s10545-010-9222-3.
65. Sweetman, L., & Williams, J. C. (2001). Branched chain organic acidurias. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (2nd ed., Vol. 8, pp. 2125-2163). New York: The McGraw-Hill Companies.
66. Topaloǧlu, R., Lebre, A. S., Demirkaya, E., et al. (2008). Two new cases with Pearson syndrome and review of Hacettepe experience. Turkish Journal of Pediatrics, 50, 572-576.
67. Topçu, M., Jobard, F., Halliez, S., et al. (2004). l-2-Hydroxyglutaric aciduria: Identification of a mutant gene Ci4orf160, localized on chromosome 14q22. 1. Human Molecular Genetics, 13, 2803-2811.
68. van Beelen, P., Labro, J. F., Keltjens, J. T., et al. (1984). Derivatives of methanopterin, a coenzyme involved in methanogenesis. European Journal of Biochemistry, 139, 359-365.
69. van Schaftingen, E., Rzem, R., & Veiga-da-Cunha, M. (2009). l-2-hydroxyglutaric aciduria, a disorder of mitochondrial repair. Journal of Inherited Metabolic Disease, 32, 135-142.
70. Verkaart, S., Koopman, W. J. H., Sjenet, E., et al. (2007). Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochimica et Biophysica Acta, 1772, 373-381.
71. Walsh, R., Conway, H., Roche, G., & Mayne, P. D. (1999). What is the origin of 3-methylglutaconic acid? Journal of Inherited Metabolic Disease, 22, 252-255.
72. Wolf, N. I., & Smeitink, J. A. M. (2002). Mitochondrial disorders: A proposal for consensus diagnostic criteria in infants and children. Neurology, 59, 1402-1405.
73. Wortmann, S., Rodenburg, R. J., Huizing, M., et al. (2005). Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation. Molecular Genetics and Metabolism, 88, 47-52.